Merck Company Stock Market Value

MRK Stock  USD 99.86  2.42  2.48%   
Merck's market value is the price at which a share of Merck trades on a public exchange. It measures the collective expectations of Merck Company investors about its performance. Merck is selling for 99.86 as of the 21st of November 2024. This is a 2.48 percent increase since the beginning of the trading day. The stock's last reported lowest price was 96.95.
With this module, you can estimate the performance of a buy and hold strategy of Merck Company and determine expected loss or profit from investing in Merck over a given investment horizon. Check out Merck Correlation, Merck Volatility and Merck Alpha and Beta module to complement your research on Merck.
Symbol

Merck Company Price To Book Ratio

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Dividend Share
3.04
Earnings Share
4.82
Revenue Per Share
24.931
Quarterly Revenue Growth
0.044
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Merck 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Merck's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Merck.
0.00
12/02/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/21/2024
0.00
If you would invest  0.00  in Merck on December 2, 2022 and sell it all today you would earn a total of 0.00 from holding Merck Company or generate 0.0% return on investment in Merck over 720 days. Merck is related to or competes with Johnson Johnson, Small Cap, Freedom Holding, Gfl Environmental, Growth Fund, Spring Valley, and Gold Fields. Merck Co., Inc. operates as a healthcare company worldwide More

Merck Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Merck's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Merck Company upside and downside potential and time the market with a certain degree of confidence.

Merck Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Merck's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Merck's standard deviation. In reality, there are many statistical measures that can use Merck historical prices to predict the future Merck's volatility.
Hype
Prediction
LowEstimatedHigh
96.3497.4498.54
Details
Intrinsic
Valuation
LowRealHigh
87.70104.40105.50
Details
Naive
Forecast
LowNextHigh
94.7795.8796.97
Details
29 Analysts
Consensus
LowTargetHigh
106.65117.20130.09
Details

Merck Company Backtested Returns

Merck Company has Sharpe Ratio of -0.19, which conveys that the firm had a -0.19% return per unit of risk over the last 3 months. Merck exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Merck's Risk Adjusted Performance of (0.16), standard deviation of 1.1, and Mean Deviation of 0.832 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Merck's returns are expected to increase less than the market. However, during the bear market, the loss of holding Merck is expected to be smaller as well. At this point, Merck Company has a negative expected return of -0.22%. Please make sure to verify Merck's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Merck Company performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.50  

Modest predictability

Merck Company has modest predictability. Overlapping area represents the amount of predictability between Merck time series from 2nd of December 2022 to 27th of November 2023 and 27th of November 2023 to 21st of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Merck Company price movement. The serial correlation of 0.5 indicates that about 50.0% of current Merck price fluctuation can be explain by its past prices.
Correlation Coefficient0.5
Spearman Rank Test0.01
Residual Average0.0
Price Variance86.08

Merck Company lagged returns against current returns

Autocorrelation, which is Merck stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Merck's stock expected returns. We can calculate the autocorrelation of Merck returns to help us make a trade decision. For example, suppose you find that Merck has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Merck regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Merck stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Merck stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Merck stock over time.
   Current vs Lagged Prices   
       Timeline  

Merck Lagged Returns

When evaluating Merck's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Merck stock have on its future price. Merck autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Merck autocorrelation shows the relationship between Merck stock current value and its past values and can show if there is a momentum factor associated with investing in Merck Company.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Merck technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Merck technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Merck trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...